Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
// Sara Alves 1 , Lisandra Castro 1 , Maria Sofia Fernandes 3 , Rita Francisco 1 , Paula Castro 1 , Muriel Priault 2 , Susana Rodrigues Chaves 1 , Mary Pat Moyer 4 , Carla Oliveira 3 , Raquel Seruca 3 , Manuela Côrte-Real 1 , Maria João Sousa 1, * , Ana Preto 1, * 1 CBMA - Centre of Molecular and Environmental Biology, Department of Biology, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal 2 CNRS, UMR5095, University de Bordeaux 2, Bordeaux, France 3 IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal 4 INCELL Corporation, San Antonio, Texas, USA * These authors have contributed equally to this work Correspondence to: Ana Preto, e-mail: apreto@bio.uminho.pt Keywords: autophagy, KRAS mutations, colorectal cancer, humanized yeast, non-cancer colon cells Received: March 27, 2015 Accepted: September 14, 2015 Published: September 25, 2015 ABSTRACT The recent interest to modulate autophagy in cancer therapy has been hampered by the dual roles of this conserved catabolic process in cancer, highlighting the need for tailored approaches. Since RAS isoforms have been implicated in autophagy regulation and mutation of the KRAS oncogene is highly frequent in colorectal cancer (CRC), we questioned whether/how mutant KRAS alleles regulate autophagy in CRC and its implications. We established two original models, KRAS-humanized yeast and KRAS-non-cancer colon cells and showed that expression of mutated KRAS up-regulates starvation-induced autophagy in both. Accordingly, KRAS down-regulation inhibited autophagy in CRC-derived cells harboring KRAS mutations. We further show that KRAS-induced autophagy proceeds via up-regulation of the MEK/ERK pathway in both colon models and that KRAS and autophagy contribute to CRC cell survival during starvation. Since KRAS inhibitors have proven difficult to develop, our results suggest using autophagy inhibitors as a combined/alternative therapeutic approach in CRCs with mutant KRAS .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jung, C. H., Ro, S.-H., Cao, J., Otto, N. M., & Kim, D.-H. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.017 · Cited by 2,090
A Comprehensive Survey of Ras Mutations in Cancer
Prior, I. A., Lewis, P. D., & Mattos, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2612 · Cited by 2,063 · cited 1×
“We established a non-cancer colon NCM460 cell model to study, in the same genetic background, the effect of overexpressing three of the most common mutant KRAS alleles that occur in CRCs: KRASG13D, KRASG12D and KRASG12V [35].”
Mammalian autophagy: core molecular machinery and signaling regulation
Yang, Z., & Klionsky, D. J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.11.014 · Cited by 1,956 · cited 1×
“Autophagy is an evolutionary conserved catabolic process in eukaryotic cells from yeast to mammals that targets cellular components for lysosomal degradation to maintain cellular homeostasis [10].”
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789
Hyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583
Pancreatic cancers require autophagy for tumor growth
Yang, S., Wang, X., Contino, G., Liesa, M., Sahin, E., Ying, H., Bause, A., Li, Y., Stommel, J. M., Dell'Antonio, G., et al. (2011) · Genes & Development · doi:10.1101/gad.2016111 · Cited by 1,498 · cited 1×
“Previous studies demonstrated that expression of HRASG12V in MEFs and HRASG12V or KRASG12V in iBMK cells promotes cell proliferation through up-regulation of autophagy [11, 16, 39].”
Ras oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467
Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis
Guo, J. Y., Chen, H.-Y., Mathew, R., Fan, J., Strohecker, A. M., Karsli-Uzunbas, G., Kamphorst, J. J., Chen, G., Lemons, J. M. S., Karantza, V., et al. (2011) · Genes & Development · doi:10.1101/gad.2016311 · Cited by 1,323 · cited 3×
“Notably, cell lines harboring RAS mutations, such as those derived from bladder (T24, HRASG12V mutation), lung (H1299, NRASG12C mutation; H460, KRASQ61H mutation), pancreatic (PANC-1, KRASG12V mutation), and colorectal cancer (HCT116, KRASG13D mutation), have high basal levels of autophagy [11].”
Yamamoto, A., Tagawa, Y., Yoshimori, T., Moriyama, Y., Masaki, R., & Tashiro, Y. (1998) · Cell Structure and Function · doi:10.1247/csf.23.33 · Cited by 1,312
Formation Process of Autophagosome Is Traced with Apg8/Aut7p in Yeast
Kirisako, T., Baba, M., Ishihara, N., Miyazawa, K., Ohsumi, M., Yoshimori, T., Noda, T., & Ohsumi, Y. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.435 · Cited by 881
Cited by
Antiproliferative and palliative activity of flavonoids in colorectal cancer
Fernández, J., Silván, B., Entrialgo-Cadierno, R., Villar, C. J., Capasso, R., Uranga, J. A., Lombó, F., & Abalo, R. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112241 · Cited by 258
Tirella, A., Kloc-Muniak, K., Good, L., Ridden, J., Ashford, M., Puri, S., & Tirelli, N. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.02.032 · Cited by 60
Autophagy: A Versatile Player in the Progression of Colorectal Cancer and Drug Resistance
Manzoor, S., Muhammad, J. S., Maghazachi, A. A., & Hamid, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.924290 · Cited by 45
“Through the MEK/ERK pathway, KRAS activating mutations increase autophagy in CRC cells, contributing to their survival under starvation conditions (23).”
Background
Metadata
- Authors
- Alves, S., Castro, L., Fernandes, M. S., Francisco, R., Castro, P., Priault, M., Chaves, S. R., Moyer, M. P., Oliveira, C., Seruca, R., Côrte-Real, M., Sousa, M. J., & Preto, A.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-09-25
- Volume
- 6
- Issue
- 31
- Pages
- 30787-30802
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1946100424
- Cited by
- 62
- References
- 16
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy. https://app.cochat.ai/papers/10.18632/oncotarget.5021
- The paper
- Alves, S., Castro, L., Fernandes, M. S., Francisco, R., Castro, P., Priault, M., Chaves, S. R., Moyer, M. P., Oliveira, C., Seruca, R., Côrte-Real, M., Sousa, M. J., & Preto, A. (2015). Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy. Oncotarget. https://doi.org/10.18632/oncotarget.5021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.